SPECIAL NOTICE
65 -- Procurement of 50mg of Mouse Fibroblast Activation Protein alpha/FAP monoclonal antibody (MAb), clone # 983802.
- Notice Date
- 7/15/2021 6:31:47 AM
- Notice Type
- Special Notice
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- NIH NCI ROCKVILLE MD 20852 USA
- ZIP Code
- 20852
- Solicitation Number
- 75N91021Q00155
- Response Due
- 7/22/2021 9:00:00 AM
- Archive Date
- 08/06/2021
- Point of Contact
- Elizabeth Tucker, Megan Kisamore, Contracting Officer
- E-Mail Address
-
elizabeth.tucker@nih.gov, megan.kisamore@nih.gov
(elizabeth.tucker@nih.gov, megan.kisamore@nih.gov)
- Description
- 1.0�� �DESCRIPTION � The U.S. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Molecular Imaging Branch (MIB) intends to procure 50mg of Mouse Fibroblast Activation Protein alpha/FAP monoclonal antibody (MAb) on a sole source basis from R&D Systems located at 614 McKinley Place NE, Minneapolis, MN 55413.� The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1(b)(1); and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541380 with a size standard number of $16.5 Million.� The anticipated award shall be a firm fixed price purchase order. It has been determined there are no opportunities to acquire green products or services for this procurement. 2.0�� �BACKGROUND The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Molecular Imaging Branch (MIB) is focused on the advancement of cancer therapies using molecular imaging. MIB conducts research in designing, developing, and testing new novel targeted imaging agents for the detection and characterization of cancer. �These imaging agents include tissue-specific Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), radionuclide, and optical probes. �MIB intends to concentrate on the clinical translation of targeted imaging and therapy agents for improving cancer therapy. Using the requested monoclonal antibody, the branch will expand the pre-clinical studies on a larger scale. 3.0�� �TYPE OF ORDER This is a Firm Fixed-Price Purchase Order. 4.0�� �SPECIAL ORDER REQUIREMENTS 4.1�� �PRODUCT FEATURES/SALIENT CHARACTERISTICS The following product features/characteristics are required of the Mouse Fibroblast Activation Protein alpha/FAP monoclonal antibody (MAb), clone # 983802: ��� �The antibody shall be a minimum of 50mg. ��� �The antibody type shall be monoclonal rat IgG1. The antibody shall be composed of single clone, as opposed to multiple clones, whose type is immunoglobulin G1 (IgG1), generated in rat (monoclonal rat IgG1). ��� �The antibody shall be capable of binding specifically to mouse FAP. ��� �Shall have a low non-specific binding to proteins other than mouse FAP (does not bind to proteins other than mouse FAP). ��� �The antibody shall be supplied in unconjugated form. ��� �The antibody shall be in a preservative free solution because preservatives are toxic to cells and animals, interfering with the studies. 4.2�� �DELIVERY The Contractor shall deliver the supplies to NCI within 3 months of award. The Contractor shall coordinate delivery and tracking information with the NCI Technical Point of Contact (TPOC), TBD at award. The Contractor shall ship the antibody on dry ice using Priority Overnight shipping. All shipping/handling (including FOB) and delivery fees shall be included.� The Contractor shall deliver the supplies to the following address: TBD at Award NCI/MIB 9000 Rockville Pike Bldg 10, Room B3B69 Bethesda, MD �20892 4.3�� �PROCEDURES DURING COVID-19 PANDEMIC Due to the current COVID-19 pandemic, the Contractor must pay close attention to the following delivery instructions. Please be aware that due to the fluidity of the existing pandemic, instructions may be updated as needed after award. -�� �The supplies shall be delivered within the timeframe listed in section 4.2 above. -�� �The Contractor shall: ��� �Store or hold supplies until NCI is ready to accept the supplies at no additional cost;� -�� �Communicate and follow instructions from the TPOC to coordinate delivery in accordance with the timeframe stated in section 4.2 above. The delivery address and TPOC�s information will be provided at the time of award and must be included as part of the order/shipping label. -�� �All companies delivering to NIH�s main campus shall comply with Commercial Vehicle Inspection Facility (CVIF) access procedures. CVIF will provide a list of buildings with loading docks. -�� �Delivered items will be logged in and the loading dock Contractor or Government employee will attempt to contact the TPOC for inspection and acceptance of the package. In the event the TPOC is unable to accept the package, the supplies shall not be left at the loading dock station. The Contractor shall confirm another attempt will be made to deliver on another date, to be coordinated with the TPOC, at no additional cost. � -�� �Deliveries shall only be made between 6AM to 4PM, Monday through Friday. Note: Delivery personnel may be asked a series of questions related to recent travels and if any physical symptoms relevant to COVID 19 exist. 5.0�� �INSPECTION AND ACCEPTANCE CRITERIA Pursuant to FAR clause 52.212-4, all supplies described in the SON to be delivered under this purchase order is subject to final inspection and acceptance by an authorized representative of the Government. The authorized representative of the Government is the NCI TPOC, who is responsible for inspection and acceptance of all services, materials, or supplies to be provided by the Contractor. Regardless of format, all digital content or communications materials produced as a deliverable under this contract, shall conform to applicable Section 508 Standards to allow Federal employees and members of the public with disabilities to have access to and use of information and data that is comparable to the access to and use of information and data by Federal employees or by members of the public who are not individuals with disabilities. Remediation of any materials that do not comply with the applicable Section 508 requirements as set forth below, shall be the responsibility of the Contractor. � HHS guidance regarding accessibility of documents can be found at https://www.hhs.gov/web/section-508/making-files-accessible/create-accessible-pdfs/index.html.� Federal government-wide guidance regarding accessibility of documents can be found at https://www.section508.gov/, including the documents describing the preferred method of authoring and testing documents produced in Microsoft Word 2013 or later, Microsoft Excel, and files formatted as PDF. 6.0�� �UNIQUE QUALIFICATIONS� R&D Systems is the distributor and sole manufacturer of the Mouse Fibroblast Activation Protein (FAP) alpha/FAP Mab (monoclonal antibody), clone #983802. The MIB has previously purchased small quantities (5mg) of the FAPalpha Mab from R&D Systems. Therefore, to be scientifically consistent with the previous findings, the MIB needs to use the same vendor for the requested larger quantity (50mG) of the antibody. The same antibody with the same clone number needs to be used in order to obtain consistent scientific results and comparability when using the same research methods and instruments. 7.0�� �SUBMISSION INFORMATION This notice is not a request for competitive quotation. However, if any interested party, especially small businesses, believes it can meet the above requirement, it may submit a capability statement, proposal, or quotation for the Government to consider. �The statement of capabilities and/or any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. �All responses must be submitted via email to Contract Specialist, Elizabeth Tucker, at elizabeth.tucker@nih.gov by no later than 12:00 PM EST on July 22, 2021. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management (SAM) through sam.gov.� Reference: 75N91021Q00155 on all correspondence. �
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/65c8a36004c148fb89bec951cf0bfe77/view)
- Place of Performance
- Address: Bethesda, MD 20892, USA
- Zip Code: 20892
- Country: USA
- Zip Code: 20892
- Record
- SN06062393-F 20210717/210715230113 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |